Metachromatic Leukodystrophy (MLD) is a fatal demyelinating lysosomal storage disease with no approved treatment; it is caused by mutation in arylsulfatase A (ARSA) gene that results in accumulation of sulphatides in neural and glial cells. This evidence concerns the gene ARSA and metachromatic leukodystrophy.